RAD51 and breast neoplasm: In agreement with these findings, we observed that the level of baseline RAD51 foci in tumor samples from the metastatic supraclavicular node and the two PDXs were intermediate and significantly different to BRCA2 wt and mutant breast tumors (Figure S7).